Semaglutide (GLP-1)

Semaglutide (Ozempic) is used primarily to treat type 2 diabetes by helping to control blood sugar levels. It is also approved for weight loss under the brand name Wegovy, for individuals with obesity or overweight conditions. Semaglutide is the active ingredient found in branded weight loss & diabetes medication like Wegovy and Ozempic.

 Semaglutide is a GLP-1 receptor agonist, meaning it mimics the action of the GLP-1 hormone in the body. It helps lower blood sugar by stimulating insulin production in response to food, reduces appetite, and slows gastric emptying, helping people feel full for longer periods.  

Semaglutide is administered as a subcutaneous injection (under the skin) typically once a week. It can be injected into the abdomen, thigh, or upper arm. You should follow your healthcare provider’s instructions on how to inject the medication properly.

Common side effects include:

Nausea

Diarrhea

Vomiting

Abdominal pain

Constipation

These side effects usually decrease over time as your body adjusts to the medication.

Yes, semaglutide can help with weight loss, especially in individuals with obesity. It works by reducing appetite and promoting a feeling of fullness, which leads to lower food intake. In clinical studies, individuals using Wegovy (semaglutide for weight loss) have seen significant reductions in body weight.

Semaglutide should be avoided by individuals who:

Have a personal or family history of medullary thyroid cancer or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

Are allergic to semaglutide or any of its components

Are pregnant or breastfeeding (consult with a healthcare provider first)

Have severe gastrointestinal problems (like gastroparesis)

Semaglutide can be used with other medications, but you should consult your doctor to ensure that there are no significant interactions. For example, it may affect the way certain drugs are absorbed, especially oral medications that require a specific absorption rate.  

For weight loss, it may take several weeks to months to notice significant changes in weight, depending on individual factors like diet, exercise, and adherence to treatment.

Coverage for Semaglutide depends on your insurance plan. It's more likely to be covered for people with type 2 diabetes. If you're using Semaglutide for weight loss, insurance coverage may be more limited. Always check with your provider or insurance company to understand your coverage.  However, our practice is a cash base practice bringing these medications to our patients for fraction of the cost that branded medications are being sold for. 

 When discussing medications, there is usually a generic name and a Brand name. 

In this case:

• Semaglutide- is the generic name
• Ozempic- is a Brand name
• Wegovy- is a Brand name

All of the medications are essentially the same and active ingredients 

Compounded semaglutide is not approved or evaluated for safety, efficacy, or quality by FDA. Ozempic® and Wegovy® are not compounded and are FDA-approved. Ozempic® (semaglutide) is FDA-approved for type 2 diabetes treatment but may be prescribed off-label for weight loss at a healthcare provider's discretion. Wegovy® (semaglutide) is FDA-approved for weight loss